| 10-year outcomes after monitoring, surgery, or radiotherapy for localized prostate cancer FC Hamdy, JL Donovan, JA Lane, M Mason, C Metcalfe, P Holding, ... New England Journal of Medicine 375 (15), 1415-1424, 2016 | 3044 | 2016 |
| Artificial intelligence for diagnosis and grading of prostate cancer in biopsies: a population-based, diagnostic study P Ström, K Kartasalo, H Olsson, L Solorzano, B Delahunt, DM Berney, ... The Lancet Oncology 21 (2), 222-232, 2020 | 520 | 2020 |
| Fifteen-year outcomes after monitoring, surgery, or radiotherapy for prostate cancer FC Hamdy, JL Donovan, JA Lane, C Metcalfe, M Davis, EL Turner, ... New England Journal of Medicine 388 (17), 1547-1558, 2023 | 346 | 2023 |
| Competition amongst Eph receptors regulates contact inhibition of locomotion and invasiveness in prostate cancer cells JW Astin, J Batson, S Kadir, J Charlet, RA Persad, D Gillatt, JD Oxley, ... Nature cell biology 12 (12), 1194-1204, 2010 | 269 | 2010 |
| Serine–arginine protein kinase 1 (SRPK1) inhibition as a potential novel targeted therapeutic strategy in prostate cancer A Mavrou, K Brakspear, M Hamdollah-Zadeh, G Damodaran, ... Oncogene 34 (33), 4311-4319, 2015 | 163 | 2015 |
| Ten-year mortality, disease progression, and treatment-related side effects in men with localised prostate cancer from the ProtecT randomised controlled trial according to … DE Neal, C Metcalfe, JL Donovan, JA Lane, M Davis, GJ Young, ... European urology 77 (3), 320-330, 2020 | 157 | 2020 |
| Correlation of upper-tract cytology, retrograde pyelography, ureteroscopic appearance, and ureteroscopic biopsy with histologic examination of upper-tract transitional cell … SK Williams, KJ Denton, A Minervini, J Oxley, J Khastigir, AG Timoney, ... Journal of endourology 22 (1), 71-76, 2008 | 137 | 2008 |
| Preoperative p53, bcl-2, CD44 and E-cadherin immunohistochemistry as predictors of biochemical relapse after radical prostatectomy SF Brewster, JD Oxley, M Trivella, CD Abbott, DA Gillatt The Journal of urology 161 (4), 1238-1243, 1999 | 120 | 1999 |
| Ketamine cystitis as a mimic of carcinoma in situ JD Oxley, AM Cottrell, S Adams, D Gillatt Histopathology 55 (6), 705-708, 2009 | 104 | 2009 |
| Patient‐reported outcomes in the ProtecT randomized trial of clinically localized prostate cancer treatments: study design, and baseline urinary, bowel and sexual function and … A Lane, C Metcalfe, GJ Young, TJ Peters, J Blazeby, KNL Avery, ... BJU international 118 (6), 869-879, 2016 | 71 | 2016 |
| Immunohistochemical staining for the differentiation of subungual keratoacanthoma from subungual squamous cell carcinoma M Connolly, S Narayan, J Oxley, DAR De Berker Clinical and experimental dermatology 33 (5), 625-628, 2008 | 61 | 2008 |
| Mortality among men with advanced prostate cancer excluded from the ProtecT trial TJ Johnston, GL Shaw, AD Lamb, D Parashar, D Greenberg, T Xiong, ... European urology 71 (3), 381-388, 2017 | 59 | 2017 |
| Metastatic renal oncocytoma JD Oxley, J Sullivan, A Mitchelmore, DA Gillatt Journal of Clinical Pathology 60 (6), 720-722, 2007 | 58 | 2007 |
| Contemporary accuracy of death certificates for coding prostate cancer as a cause of death: Is reliance on death certification good enough? A comparison with blinded review by … EL Turner, C Metcalfe, JL Donovan, S Noble, JAC Sterne, J Lane, ... British journal of cancer 115 (1), 90-94, 2016 | 54 | 2016 |
| Ductal carcinomas of the prostate: a clinicopathological and immunohistochemical study Oxley, Abbott, Gillatt, Maciver British journal of urology 81 (1), 109-115, 1998 | 53 | 1998 |
| Her-2/neu oncogene amplification in clinically localised prostate cancer JD Oxley, MH Winkler, DA Gillatt, DS Peat Journal of Clinical Pathology 55 (2), 118-120, 2002 | 52 | 2002 |
| Functional and quality of life outcomes of localised prostate cancer treatments (Prostate Testing for Cancer and Treatment [ProtecT] study) JA Lane, JL Donovan, GJ Young, M Davis, EI Walsh, KNL Avery, ... BJU international 130 (3), 370-380, 2022 | 51 | 2022 |
| Quantitative Analysis of ERG Expression and Its Splice Isoforms in Formalin-Fixed, Paraffin-Embedded Prostate Cancer Samples: Association With Seminal Vesicle … RM Hagen, P Adamo, S Karamat, J Oxley, JJ Aning, D Gillatt, R Persad, ... American journal of clinical pathology 142 (4), 533-540, 2014 | 51 | 2014 |
| The ProtecT trial: analysis of the patient cohort, baseline risk stratification and disease progression RJ Bryant, J Oxley, GJ Young, JA Lane, C Metcalfe, M Davis, EL Turner, ... BJU international 125 (4), 506-514, 2020 | 49 | 2020 |
| p53 and bcl‐2 immunohistochemistry in preoperative biopsies as predictors of biochemical recurrence after radical prostatectomy JD Oxley, MH Winkler, K Parry, S Brewster, C Abbott, DA Gillatt BJU international 89 (1), 27-32, 2002 | 49 | 2002 |
